1. Jiading District Center for Disease Control and Prevention, Shanghai 201899, China; 2. School of Public Health, Fudan University, Shanghai 200032, China
摘要目的 探讨甲状腺疾病与心血管疾病及相关危险因素的相关性。 方法 利用上海市公共卫生与预防医学“高峰计划”学科建设中健康人群队列项目数据,采用问卷调查和生化指标了解人群的基本情况、慢性病病史及相关生化指标分布。 结果 本次共调查10 051人,892人(8.87%)患有甲状腺疾病,女性患病率(12.18%)高于男性(3.91%)(P=0.000)。被诊断为患有高血压、糖尿病及发生过脑卒中患者与未患有该类疾病患者其甲状腺疾病患病情况均无差异(9.15% vs. 8.71%、9.20% vs. 8.84%、10.73% vs. 8.77%)(P均>0.05);高脂血症患者甲状腺疾病患病率(11.79%)高于未患有高血脂者(8.38%),冠心病患者甲状腺疾病患病率(14.46%)高于未患有冠心病者(8.54%)(P<0.05)。女性甲状腺疾病患者其高脂血症、冠心病及脑卒中患病率均明显高于未患有这三种疾病者(16.89% vs. 11.44%、20.53% vs. 11.68%、16.18% vs. 11.94%)(P均<0.05),以上指标在男性中均无差异。甲状腺疾病患者的LDL-C、HDL-C及TC水平均高于未患有该病者[(2.75±0.84)mmol/L vs. (2.63±0.81)mmol/L、(1.42±0.33)mmol/L vs. (1.36±0.33)mmol/L、(5.00±0.95)mmol/L vs. (4.84±0.91)mmol/L,P均<0.001]。 结论 甲状腺疾病与心血管疾病及其危险因素之间存在相关,对于有心血管疾病或有相关危险因素者,尤其是患甲状腺疾病女性,应密切监测其甲状腺功能,积极预防心血管病的发生。
Abstract：Objective To explore the relationship of thyroid disease with cardiovascular disease and its related risk factors. Methods We used the data about the healthy population cohort project in the subject construction of the “Peak Program” of Public Health and Preventive Medicine in Shanghai Municipality. Questionnaire survey and biochemical index examination were conducted to investigate the subjects’ general information, history of chronic diseases and distribution of related biochemical indexes. Results A total of 10,051 subjects were surveyed. 892 (8.87%) subjects had thyroid disease, and the prevalence rate of the disease was higher in females than in males (12.18% vs. 3.91%, P=0.000). No statistically significant differences were found in the prevalence rate of thyroid disease between patients diagnosed with and without hypertension, diabetes and stroke (9.15% vs. 8.71%, 9.20% vs. 8.84%, 10.73% vs. 8.77%; all P>0.05). The prevalence rate of thyroid disease was higher in patients with hyperlipidemia than in patients without hyperlipidemia (11.79% vs. 8.38%) as well as higher in patients with coronary heart disease than in patients without coronary heart disease (14.46% vs. 8.54%, P<0.05). The prevalence rates of hyperlipidemia, coronary heart disease and stroke were significantly higher in women with thyroid disease than in women without the three diseases (16.89% vs. 11.44%, 20.53% vs. 11.68%, 16.18% vs. 11.94%; P<0.05), but no statistically significant differences were observed in the above-mentioned indexes in men. Patients with thyroid disease had higher levels of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and total cholesterol (TC) than those without the disease ((2.75±0.84) mmol/L vs. (2.63±0.81) mmol/L, (1.42±0.33) mmol/L vs. (1.36±0.33) mmol/L, (5.00±0.95) mmol/L vs. (4.84±0.91) mmol/L; all P<0.05). Conclusions Thyroid disease is associated with cardiovascular disease and its risk factors. As for people with cardiovascular disease or its related risk factors, especially women with thyroid disease, thyroid function should be closely monitored to actively prevent the occurrence of cardiovascular disease.
[1] Kim HJ, Bae JC, Park HK, et al. Association of triiodothyronine levels with future development of metabolic syndrome in euthyroid middle-aged subjects: a 6-year retrospective longitudinal study[J].Eur J Endocrinol,2017,176(4):443-452. [2] 张冰,吴刚,马金国,等.亚临床甲状腺功能减退症与冠心病的关系[J].中国现代医药杂志,2015,17(8):76-78. [3] 卢振华,马勇翔,张靖,等.甲状腺功能亢进相关心血管疾病的研究进展[J].中国医师杂志,2019,21(10):1588-1591. [4] Hyland KA, Arnold AM, Lee JS, et al. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study[J]. J Clin Endocrinol Metab,2013,98(2):533-540. [5] 高慧,李春江.促甲状腺激素与心血管系统疾病的研究进展[J].心血管病学进展,2019,40(2):191-194. [6] 吕露露,孙良阁.甲状腺功能与代谢综合征的相关性[J].河南医学研究,2019,28(21):4032-4034. [7] Roef GL, Rietzschel ER,Van Daele CM,et al. Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects[J].Thyroid,2014,24(2):223-231. [8] Delitala AP, Fanciulli G,Maioli M, et al. Subclinical hypothyroidism, lipid metabolism and cardiovascular disease[J]. Eur J Intern med, 2017,38:17-24. [9] 戴立新.亚临床甲状腺功能减退症与冠状动脉粥样硬化性心脏病的相关性[J].实用临床医药杂志,2014,18(15):128-129. [10] 孙晶,牛慧琴,孙培伟,等.亚临床甲状腺功能亢进与冠心病相关性的meta分析[J].中国循证医学杂志,2017,17(12):1442-1449. [11] 张曦元,赵献明.亚临床甲减对老年高血压患者颈动脉粥样硬化的影响[J].中国老年学杂志,2011,31(10):1751-1753. [12] Jun JE, Jin SM, Jee JH, et al. TSH increment and the risk of incident type 2 diabetes mellitus in euthyroid subjects[J]. Endocrine,2017,55(3):944-953. [13] 漆莉莹,胡玲,尹晓玲,等. 2型糖尿病患者甲状腺激素水平变化的研究[J].中国糖尿病杂志,2019,27(12):903-907. [14] Elmenshawy I. Prevalence of thyroid dysfunction in diabetic patients[J].J Diabetes Metab Disord, 2017,4(2):1-7. [15] 谢朝辉,姜梅,杜安妹,等. 功能社区电力职业人群代谢综合征相关因素的流行趋势分析[J]. 实用预防医学, 2015, 22(4):451-456. [16] 吴瑛, 吴芳兰, 黄蕾. 促甲状腺激素水平对妊娠期糖尿病及其对妊娠结局的影响[J]. 实用预防医学, 2018, 25(7):870-871. [17] 钱巧慧, 方琦, 郭建, 等. 非酒精性脂肪肝患者胰岛素抵抗程度与甲状腺结节的相关性研究[J]. 实用预防医学, 2018, 25(6):717-719. [18] Cho JH, Kim HJ, Lee JH, et al. Poor glycemic control is associated with the risk of subclinical hypothyroidism in patients with type 2 diabetes mellitus[J].Korean J Intern Med,2016,31(4):703-711. [19] Fu X, Xia H, Mao H,et al. The effect of glycaemic control in type 2 diabetic patients with subclinical hypothyroidism [J]. J Endocrinol Invest,2016,39(12):1453-1458. [20] 杨洋,时立新,张巧,等. 贵阳市城区40~80岁居民正常血清TSH 水平与代谢综合征及其组分的相关性研究[J].中华内分泌代谢杂志,2018,34(1):34-37. [21] 吴晓晶.甲状腺功能正常中青年血清促甲状腺激素水平与代谢综合征的相关性研究[J].临床医学进展,2018,8(7):603-609. [22] Angelin B, Rudling M.Lipid lowering with thyroid hormone and thyromimetics[J].Curr Opin Lipidol,2010,21(6):499-506.
2021, Vol. 28 
